View Post

UChicago Medicine enrolling patients in LymphBridge™ clinical study for surgical treatment of breast cancer-related lymphedema

In In The News by Barbara Jacoby

By: University of Chicago Medical Center From: newswise.com The University of Chicago Medicine has announced today that it is now enrolling patients in LymphBridge™, a randomized clinical study to evaluate a novel surgical treatment for addressing breast cancer-related lymphedema. This study is sponsored by Fibralign Corporation with funding provided by the National Cancer Institute (NCI) and being led by world-renowned …

View Post

Considering Lymphedema Is Key for Multimodality Therapy of Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Audrey Sternberg From: cancernetwork.com Susan B. Kesmodel, MD, FACS, of the University of Miami, describes 3 methods by which breast surgical oncologists can strategize to reduce the incidence of lymphedema in patients undergoing surgery for breast tumors. When considering management of the axilla in patients undergoing surgical procedures for breast cancer, it is important to consider lymphedema, particularly when …

View Post

Congress must close gaps in insurance for breast cancer patients | PennLive letters

In In The News by Barbara Jacoby

From: pennlive.com World Cancer Day was celebrated Feb. 4, and I would like to draw attention to the often neglected survivorship issue of lymphedema. This incurable, but treatable condition affects 15% of cancer survivors overall, 40% of all breast cancer survivors as well as others, like myself, who suffer from the condition and didn’t have cancer surgery. When cancer treatments …

View Post

Education-Only, Exercise Intervention-Based Programs Helped Reduce Lymphedema Incidence and Increase Range of Motion in Affected Limbs of Patients Treated for Breast Cancer

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com An education-only and education plus sleeve compression/exercise intervention program were similarly effective in reducing lymphedema incidence in women with breast cancer 18 months following the surgical removal of one or more of their lymph nodes, according to data recently published in Cancer. Of note, the study results also indicated that women in the education plus …

View Post

PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema

In In The News by Barbara Jacoby

From: businesswire.com Study will further evaluate safety and tolerability of LYT-100 and explore clinical efficacy endpoints in patients with breast-cancer related, upper limb secondary lymphedema Previously announced results from multiple ascending dose and food effect study in healthy volunteers demonstrated favorable tolerability and pharmacokinetic proof-of-concept for LYT-100 A separate Phase 2 study evaluating LYT-100 in Long COVID respiratory complications and …

View Post

Randomized Study Reveals Challenges in Lymphedema Prevention for Breast Cancer Survivors

In Clinical Studies News by Barbara Jacoby

By: Susan Moench, PhD, PA-C From: oncologynurseadvisor.com At a follow-up of 18 months, addition of a sleeve compression/exercise intervention to standard education focused on lymphedema risk reduction did not significantly decrease the incidence of lymphedema following surgery in women with early-stage breast cancer, according to results of a randomized clinical trial published in Cancer. Lymphedema, an accumulation of lymphatic fluid …

View Post

Breast cancer: How to recognize and treat lymphedema

In In The News by Barbara Jacoby

By: sharrell@themountaineer.com From: themountaineer.com Lymph is a clear fluid that contains antibodies and flows through the lymphatic system of the body. If this fluid is unable to properly circulate, it can build up in the soft tissue of a limb and cause swelling. This condition, called lymphedema, is common in breast cancer patients whose lymph nodes have been damaged or …

View Post

Consensus Called for When Choosing Optimal Treatment for Breast Cancer–Related Lymphedema

In In The News by Barbara Jacoby

By: Maggie L. Shaw From: ajmc.com More than 20% of breast cancer survivors are severely affected by upper-limb breast cancer–related lymphedema (BCRL), which has debilitating adverse effects that include depression, chronic pain, functional impairment, recurrent skin infections, poor body image, and anxiety—all having an impact on overall long-term health-related quality of life (HRQOL). The 2 principal treatment modalities are complex …

View Post

Adverse Effects of Breast Cancer Treatment Shown Through App

In In The News by Barbara Jacoby

By: Jill Murphy, Assistant Editor From: pharmacytimes.com Emerging app-based technology now makes early detection of severe adverse effects (AEs) from breast cancer treatment easier for women, according to a new study conducted by Georgia Tech. A severe AE of breast cancer, lymphedema, can affect approximately 20% of survivors of the disease and is often overlooked, according to the researchers. Lymphedema …

View Post

App Detects Harsh Side Effect of Breast Cancer Treatment

In In The News by Barbara Jacoby

From: gatech.edu Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment. The lymphedema monitoring technology originated through research at the Georgia Institute of Technology and was …